Assessment of cognitive safety in clinical drug development Review published in Drug Discovery Today November 2015. Jonathan P. Roiser, Pradeep J. Nathan, Adrian P. Mander, Gabriel Adusei, Kenton H. Zavitz, Andrew D. Blackwell Download Download form Please complete all fields marked* First name * Last name * Organisation / Institution * Email * Telephone * Country * Please select United Kingdom United States Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic of The Cook Islands Costa Rica Cote D'ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory, Occupied Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Area of interest * Please select Abuse Liability AD / MCI / prodromal AD Addiction ADHD Antivirals Allergies Alzheimer's disease Anxiety disorders/stress Autism Bipolar disorder Cancer Cardiovascular Cognitive Enhancement Cognitive Safety Core Cognition Dementia Depression Developmental Disorders Diabetes Drug Interaction Down’s Syndrome Eating disorders Epilepsy Fragile X General cognition Genetic disorders Hearing Disorders HIV Huntington's disease Impulse-control disorders Migraine Mild cognitive impairment Mood Movement Multiple Sclerosis Neuromuscular Disease Nutrition Obesity Other dementias Pain Pain disorders Parkinson's disease Respiratory Schizophrenia Sleep Sports injury Stroke Substance abuse Systemic Lupus Traumatic Brain Injury (TBI) Where did you hear about us? Please select Search engine Email Social media Press Research paper Conference/event Recommendation Other We would like to keep you informed with the latest news, data and innovations from the neuroscience and clinical trial community. We'll always treat your contact information with great care and will never allow other companies to access your information for marketing purposes. Please let us know if you would like us to contact you or not by selecting one of the options below. Yes please, I would like to stay up to date with the neuroscience research and clinical trial communities. No thanks, I don't want to hear about the latest news, scientific data and technology innovations. This field is intended to catch out spammers - please leave it blank. Share this
